Hatmi Zinat Nadia, Jalilian Nasrin, Pakravan Ali
Department of Preventive Medicine, Medical School, Tehran University of Medical Sciences, Tehran, Iran.
Department of Epidemiology, Centre for Public Health, Medical University of Vienna, Vienna, Austria.
Adv J Emerg Med. 2019 May 12;3(3):e24. doi: 10.22114/ajem.v0i0.149. eCollection 2019 Summer.
So far, there is no evidence available to demonstrate the relationship between five subgroups of total cholesterol/high density lipoprotein cholesterol (TC/HDL-C) ratio with premature myocardial infarction (MI).
We conducted a case control study to probe more features of the relation between TC/HDL-C ratio and the five subgroups of the ratio with myocardial infarction under 55 years and above it.
A hospital based case control study with incident cases was designed. Cases and controls were comprised of 523 under 55-year and 699 above 55-year documented newly diagnosed MI cases, respectively. Standardized clinical and para clinical method were used to ascertain disease and risk factors. Independent sample t-test, Pearson chi square test, Odds ratios and Mantel-Haenszel test and logistic regression analysis conducted to evaluate relationships.
This study enrolled 1222 MI cases. Patients with very low risk category of TC/HDL-C ratio estimated OR=0.18 with 95% confidence interval (CI) (0.04-0.72) for developing MI under 55 years. Patients who had low risk category of TC/HDL-C ratio having OR=0.26 95% CI (0.07-0.89). Low risk and very low risk categories of the TC/HDL-C ratio compare to high risk subgroup of the ratio demonstrate decreased risk of developing MI under 55 years p<0.05.
Our study results can be translated as an aggressive treatment for lowering TC/HDL-C ratio in both general population and victims of coronary events. Mitigation of the level of TC/HDL-C ratio from low risk to very low risk category will attenuate the risk of MI under55 years about 8% which is the immediate clinical implication of our findings.
到目前为止,尚无证据表明总胆固醇/高密度脂蛋白胆固醇(TC/HDL-C)比值的五个亚组与早发心肌梗死(MI)之间的关系。
我们进行了一项病例对照研究,以探究TC/HDL-C比值及其五个亚组与55岁及以上心肌梗死之间关系的更多特征。
设计了一项基于医院的新发病例病例对照研究。病例组和对照组分别由523例55岁以下和699例55岁及以上新诊断的MI病例组成。采用标准化的临床和辅助临床方法确定疾病和危险因素。采用独立样本t检验、Pearson卡方检验、优势比和Mantel-Haenszel检验以及逻辑回归分析来评估关系。
本研究纳入了1222例MI病例。TC/HDL-C比值处于极低风险类别的患者,55岁以下发生MI的估计优势比(OR)=0.18,95%置信区间(CI)为(0.04-0.72)。TC/HDL-C比值处于低风险类别的患者,OR=0.26,95%CI为(0.07-0.89)。与TC/HDL-C比值的高风险亚组相比,低风险和极低风险类别的TC/HDL-C比值表明55岁以下发生MI的风险降低,p<0.05。
我们的研究结果可转化为对普通人群和冠心病患者积极降低TC/HDL-C比值的治疗方法。将TC/HDL-C比值从低风险类别降至极低风险类别可使55岁以下MI的风险降低约8%,这是我们研究结果的直接临床意义。